Global Med Technologies(R)' Systems Now in All 50 States
February 12 2009 - 9:00AM
PR Newswire (US)
Vermont Becomes 50th State to License Global Med Software DENVER,
Feb. 12 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc.
("Global Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) ,
an international e-Health, medical information technology company,
today announced that its Wyndgate Technologies(R) division has
licensed its SafeTrace Tx(R) transfusion management system to
Brattleboro Memorial Hospital of Vermont. Terms of the agreement
were not disclosed. (LOGO:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Thomas
F. Marcinek, President and COO for Global Med Technologies, stated,
"The licensing of SafeTrace Tx to Brattleboro Memorial Hospital of
Vermont is an exciting milestone for our Company. In addition to
our client base in over 20 countries, Global Med's donor and
transfusion management systems are now licensed to healthcare
organizations in all 50 states and Puerto Rico. As our products and
services continue to gain market share, both domestically and
internationally, our clients' confidence in our products and our
ability to meet their diverse needs is very gratifying." SafeTrace
Tx is transfusion management software which provides comprehensive
tracking of orders, specimens, blood products, derivatives, and
accessories with a complete testing and transfusion history in one
consolidated record. These powerful features will assist
Brattleboro Memorial Hospital's technologists in selecting
appropriate blood products for their patients and help to reduce
waste and increase efficiency in their blood bank. Wm. Scott
Dustin, Senior Vice President of Sales and Marketing for Global Med
Technologies, commented, "We are pleased that Brattleboro Memorial
Hospital has chosen our Company to provide quality software and
services for their blood bank. Our SafeTrace Tx product is a leader
among transfusion management systems and we are pleased that it
will be supporting the hospital's staff as they continue to provide
quality healthcare to patients in their community." About
Brattleboro Memorial Hospital Brattleboro Memorial Hospital ("BMH")
is a modern, well-equipped and professionally staffed community
hospital which has been serving greater Brattleboro, Vermont and
the tri-state area since 1904. Throughout more than a century of
caring for the community, BMH has kept abreast with medical
technology and has drawn excellent physicians to their facility.
The BMH medical staff boasts more than 100 board-certified
physicians, active in both primary care and many specialties. About
Global Med Technologies(R), Inc. Global Med Technologies, Inc. is
an international medical software company which develops regulated
and non-regulated products and services for the healthcare
industry. As a leading provider of blood and laboratory systems and
services, Global Med's products are deployed in 20 countries and
serve over 1,600 transfusion centers, blood banks and laboratories.
Global Med's domestic companies are Wyndgate Technologies(R), a
leader in software products and services for donor centers and
hospital transfusion services; eDonor(R), which offers web-based
donor relationship management systems; and PeopleMed(TM), Inc.,
which implements cost-effective software validation, consulting and
compliance solutions to hospitals and donor centers. Global Med's
European subsidiary, Inlog, SA, is a leading developer of donor
center and transfusion management systems as well as cellular
therapy software, laboratory information systems and quality
assurance medical software systems internationally. For more
information about Global Med's products and services, please call
800-996-3428 or visit http://www.globalmedtech.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release. Company Contact:
Global Med Technologies, Inc. Michael I. Ruxin, M.D. (303) 238-2000
Investor Contact: Global Med Technologies, Inc. Karen Davis, CFO
(916) 404-8495
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies
CONTACT: Company, Michael I. Ruxin, M.D., +1-303-238-2000, , or
Investors, Karen Davis, CFO, +1-916-404-8495, , both of Global Med
Technologies, Inc. Web Site: http://www.globalmedtech.com/
Copyright